Picture of Getinge publ AB logo

GETI B Getinge publ AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Getinge Proposes Dividend Of SEK 4.4 Per Share

Feb 1 (Reuters) - Getinge AB  GETIb.ST :
    * PROPOSES DIVIDEND OF SEK 4.40 PER SHARE VERSUS IBES
ESTIMATE SEK
4.1 PER SHARE
    * OUTLOOK 2024: NET SALES FOR 2024 ARE EXPECTED TO INCREASE
BY
2–5% ORGANICALLY
    * SALES OF HARDWARE IN CARDIAC ASSIST CONTINUED TO RECOVER,
WHICH
HAD SUBSTANTIALLY POSITIVE EFFECT ON SALES FOR ACUTE CARE
THERAPIES
    * SALES INCREASED IN LIFE SCIENCE WHERE SLIGHT RECOVERY WAS
NOTED
IN BIOPHARMA SEGMENT
    * SURGICAL WORKFLOWS REPORTED STRONG QUARTER FOR ALL PRODUCT
CATEGORIES, WITH ORGANIC GROWTH OF 15.6%
    * ORDER INTAKE INCREASED BY 4.1% IN THE QUARTER, DRIVEN BY
ACQUISITIONS AND CURRENCY
    * DESPITE WEAKER ORDER INTAKE, EXISTING ORDER BOOK AND
DIALOGUE
WITH CUSTOMERS LEAD US TO EXPECT ORGANIC SALES GROWTH OF 2-5%
FOR 2024
    * TWO ACQUISITIONS COMPLETED IN Q4 2023 ARE EXPECTED TO
CONTRIBUTE
WITH 3-5% SALES GROWTH IN 2024
    * ADJUSTED EBITA MARGIN LOWER THAN 2022, MAINLY DUE TO THE
QUALITY
COSTS FOR QUALITY IMPROVEMENT WORK IN ACUTE CARE THERAPIES
    * QUALITY COSTS EXPECTED TO CONTINUE TO AFFECT INTO 2024,
UNTIL WE
HAVE RECTIFIED THE CURRENT DEFICIENCIES
    * MARGIN WAS NEGATIVELY IMPACTED BY GENERALLY UNFAVORABLE
GEOGRAPHIC AND PRODUCT-RELATED MIX AND HIGHER COSTS FOR INPUT
GOODS AND EMPLOYEES
    * LIFE SCIENCE INCREASED ORDER INTAKE IN ALL PRODUCT
CATEGORIES
EXCEPT FOR BIO-PROCESSING, TREND IN THE US WAS STRONG WHILE
ORDER INTAKE IN CHINA REMAINED WEAK

Source text for Eikon:  ID:nWkr3tNylb 
Further company coverage:  GETIb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Getinge publ AB

See all news